Stocksigma LogoStocksigma Logo

Sun Pharma Advanced Research Company Ltd - Financial Result for the Quarter ended 30th Sep'26

■ Revenue: 3,003 (+282.1% YoY | -24.8% QoQ) ■ EBITDA: -4,561 (+30.6% YoY | -34.1% QoQ) ■ EBITDA Margin (%): -152 (+68425 bps YoY | -6671 bps QoQ) ■ PAT

Sun Pharma Advanced Research Company Ltd - Financial Result for the Quarter ended 30th Sep'26

Sun Pharma Advanced Research Company Ltd · Outcome · 03 Nov 2026, 1:16 am

Sun Pharma Advanced Research Company Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 3,003 (+282.1% YoY | -24.8% QoQ) ■ EBITDA: -4,561 (+30.6% YoY | -34.1% QoQ) ■ EBITDA Margin (%): -152 (+68425 bps YoY | -6671 bps QoQ) ■ PAT: -2,439 (+67.8% YoY | -17.4% QoQ) ■ EPS (INR): -0.75 (+67.9% YoY | -17.2% QoQ)

Original exchange filing (PDF)

More announcements from Sun Pharma Advanced Research Company Ltd

All Sun Pharma Advanced Research Company Ltd announcements